Elanco Animal Health Incorporated

29.75+0.1500+0.51%Vol 2.59M1Y Perf 21.24%
Apr 9th, 2021 16:00 DELAYED
BID27.76 ASK30.30
Open29.58 Previous Close29.60
Pre-Market- After-Market-
 - -  - -%
Target Price
33.86 
Analyst Rating
Moderate Buy 1.80
Potential %
13.82 
Finscreener Ranking
★★★★     53.52
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     47.44
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     47.13
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap14.07B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
69.22 
Earnings Date
7th May 2021

Today's Price Range

29.5830.22

52W Range

18.3734.81

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
3.33%
1 Month
-9.13%
3 Months
-5.19%
6 Months
-10.12%
1 Year
21.24%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ELAN29.750.15000.51
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
0.80
1.60
0.40
0.72
-3.50
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
49.10
-8.60
4.40
-4.60
-19.87
RevenueValueIndustryS&P 500US Markets
2.62B
5.53
-3.00
-0.30
Earnings HistoryEstimateReportedSurprise %
Q04 20200.090.1233.33
Q03 20200.120.138.33
Q02 20200.020.09350.00
Q01 20200.240.13-45.83
Q04 20190.230.230.00
Q03 20190.260.3015.38
Q02 20190.260.287.69
Q01 20190.220.2513.64
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.2321.05Positive
6/2021 QR0.24-4.00Negative
12/2021 FY0.966.67Positive
12/2022 FY1.280.79Positive
Next Report Date7th May 2021
Estimated EPS Next Report0.23
Estimates Count6
EPS Growth Next 5 Years %36.20
Volume Overview
Volume2.59M
Shares Outstanding472.80M
Trades Count17.96K
Dollar Volume171.83M
Avg. Volume3.96M
Avg. Weekly Volume2.87M
Avg. Monthly Volume4.44M
Avg. Quarterly Volume4.10M

Elanco Animal Health Incorporated (NYSE: ELAN) stock closed at 29.75 per share at the end of the most recent trading day (a 0.51% change compared to the prior day closing price) with a volume of 2.61M shares and market capitalization of 14.07B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 6080 people. Elanco Animal Health Incorporated CEO is Jeffrey N. Simmons.

The one-year performance of Elanco Animal Health Incorporated stock is 21.24%, while year-to-date (YTD) performance is -3%. ELAN stock has a five-year performance of %. Its 52-week range is between 18.37 and 34.81, which gives ELAN stock a 52-week price range ratio of 69.22%

Elanco Animal Health Incorporated currently has a PE ratio of -23.00, a price-to-book (PB) ratio of 1.64, a price-to-sale (PS) ratio of 5.23, a price to cashflow ratio of 83.40, a PEG ratio of 2.32, a ROA of -4.08%, a ROC of -1.54% and a ROE of -7.72%. The company’s profit margin is -19.87%, its EBITDA margin is 4.40%, and its revenue ttm is $2.62 Billion , which makes it $5.53 revenue per share.

Of the last four earnings reports from Elanco Animal Health Incorporated, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.23 for the next earnings report. Elanco Animal Health Incorporated’s next earnings report date is 07th May 2021.

The consensus rating of Wall Street analysts for Elanco Animal Health Incorporated is Moderate Buy (1.8), with a target price of $33.86, which is +13.82% compared to the current price. The earnings rating for Elanco Animal Health Incorporated stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Elanco Animal Health Incorporated has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Elanco Animal Health Incorporated has a Neutral technical analysis rating based on Technical Indicators (ADX : 12.26, ATR14 : 1.39, CCI20 : 106.73, Chaikin Money Flow : 0.14, MACD : 0.55, Money Flow Index : 61.04, ROC : 6.54, RSI : 60.33, STOCH (14,3) : 69.39, STOCH RSI : 0.43, UO : 50.48, Williams %R : -30.61), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Elanco Animal Health Incorporated in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (60.00 %)
5 (50.00 %)
5 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (10.00 %)
Hold
4 (40.00 %)
5 (50.00 %)
4 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.80
Moderate Buy
2.00
Moderate Buy
1.85

Elanco Animal Health Incorporated

Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Latin America, and the Asia Pacific with the highest revenue from the North America segment. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

CEO: Jeffrey N. Simmons

Telephone: +1 877 352-6261

Address: 2500 Innovation Way, Greenfield 46140, IN, US

Number of employees: 6 080

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

47%53%

Bearish Bullish

50%50%

News

Stocktwits